EQSAdhoc: Takeda Pharmaceutical Company Limited / Key words: Strategic Company Decision
Takeda Pharmaceutical Company Limited: Takeda Announces Enterprisewide Program to Support Growth and Deliver Core Operating Profit Margin Improvement
09May2024 / 08:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitte... Lire le communiqué |
|
|
|
|
EQSAdhoc: Takeda Pharmaceutical Company Limited / Key words: Forecast
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2023 IFRS
26Oct2023 / 08:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by EQS News a service of EQS... Lire le communiqué |
|
|
|
|
DGAPAdhoc: Takeda Pharmaceutical Company Limited / Key words: Forecast
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 IFRS
03Feb2022 / 07:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Group AG.
The issuer is sol... Lire le communiqué |
|
|
|
|
DGAPAdhoc: Takeda Pharmaceutical Company Limited / Key words: Forecast
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 IFRS
04Feb2021 / 07:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Group AG.
The issuer is sol... Lire le communiqué |
|
|
|
|
DGAPAdhoc: Takeda Pharmaceutical Company Limited / Key words: Forecast
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 IFRS
31Jul2020 / 08:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Group AG.
The issuer is solely responsible for the... Lire le communiqué |
|
|
|
|
DGAPAdhoc: Takeda Pharmaceutical Company Limited / Key words: Forecast
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 IFRS
04Feb2020 / 07:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Group AG.
The issuer is solely responsible for the... Lire le communiqué |
|
|
|
|